Article
ATF3-induced activation of the NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma
2023-07-25
Abstract excerpt
<h4>Purpose: </h4> Olaparib, an inhibitor of poly-(adenosine diphosphate-ribose) polymerase (PARP), has been shown to have anticancer benefits in patients with pancreatic cancer who have a germline mutation in BRCA1/2. However, resistance acquired on long-term exposure to olaparib significantly impedes clinical efficacy. Methods In this study, the chromatin accessibility and differentially expressed transcripts o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8c8944c0-f24c-53e9-a12a-ad45cbca58f4
- DOI
- 10.21203/rs.3.rs-3172142/v1
